{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-24-007044","form_type":"8-K","ticker":null,"cik":"0001098880","company_name":"IntelGenx Technologies Corp.","filed_at":"2024-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.358007+00:00","generated_at":"2026-06-04T08:20:28.082036+00:00","sec_items":["1.01","2.03","3.02"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"IntelGenx enters amended loan with ATAI; gets $1M now, $1M milestone loan; issues 4M warrants","bullets":["New $1M First Tranche loan disbursed within 3 business days of March 11; $1M Second Tranche tied to successful VLS-01 OTF Ph1 readout.","Conversion price for First Tranche set at US$0.185/share; Second Tranche uses greater of $0.185 or 5-day VWAP less max TSX discount.","4,000,000 warrants issued to ATAI at US$0.17/share, exercisable for 36 months; all securities unregistered under Section 4(a)(2).","Existing loans amended and restated; Additional Term Loans mature Feb 1, 2026; interest at 14% per annum on new loans.","Proceeds used for general corporate purposes, working capital, R&D."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-24-007044","json":"https://secwatch.observer/filing/0001062993-24-007044.json","markdown":"https://secwatch.observer/filing/0001062993-24-007044.md","text":"https://secwatch.observer/filing/0001062993-24-007044.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1098880/000106299324007044/0001062993-24-007044-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1098880/000106299324007044/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T08:20:28.082036+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e0d07b11bae2d5c8058cd6459d2c8ac9fee10144","claim":"IntelGenx Technologies Corp. incurred term loan of US$1,000,000 with ATAI Life Sciences AG maturing February 1, 2026.","evidence_excerpt":"(i) one (1) additional term loan in the amount of US$1,000,000 to IntelGenx Corp., which loan is to be disbursed within three (3) business days of the execution of the Loan Agreement (the \" First Tranche Loan \")","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1098880/000106299324007044/0001062993-24-007044-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"US$1,000,000"},{"label":"Counterparty","value":"ATAI Life Sciences AG"},{"label":"Maturity","value":"February 1, 2026"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"e0d07b11bae2d5c8058cd6459d2c8ac9fee10144","claim":"IntelGenx Technologies Corp. incurred term loan of US$1,000,000 with ATAI Life Sciences AG maturing February 1, 2026.","evidence_excerpt":"(ii) one (1) additional term loan in the amount of US$1,000,000 to IntelGenx Corp., which loan is to be disbursed upon the achievement of a pre-defined milestone (the \" Second Tranche Loan \"","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1098880/000106299324007044/0001062993-24-007044-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"US$1,000,000"},{"label":"Counterparty","value":"ATAI Life Sciences AG"},{"label":"Maturity","value":"February 1, 2026"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"c15832cfb1f8c3e4673b82fc759c57d953a77dea","claim":"IntelGenx Technologies Corp. amended Third Amended and Restated Loan Agreement with ATAI Life Sciences AG (effective 2024-03-11).","evidence_excerpt":"IntelGenx Technologies Corp. (the \" Corporation \") entered into a Third Amended and Restated Loan Agreement dated March 11, 2024 (the \" Loan Agreement \") with its wholly-owned subsidiary, IntelGenx Corp., and ATAI Life Sciences AG (\" atai \"), which amends and restates the Second Amended and Restated Loan Agreement","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1098880/000106299324007044/0001062993-24-007044-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"ATAI Life Sciences AG"},{"label":"Effective","value":"2024-03-11"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}